Industry News

Resirene & Foster Corp. Form Partnership to Pursue Medical Market for SMMA

Published on 2017-11-01. Author : SpecialChem

Resirene and Foster Corporation have formed a partnership to pursue the medical market for Resirene’s CET® SMMA styrene-acrylic copolymers.

Distribution Partnership

Foster Corporation will serve as an exclusive distributor for the medical industry in USA and Canada territory and also leverage its manufacturing capabilities within its core compounding business to provide custom SMMA functionality, including colors, impact modifiers and other specialty enhancements.

SMMA to Displace SAN and PMMA

Resirene’s CET® SMMA combines the ease of processing of styrene polymers with the crystal clarity of straight acrylic. It also provides an ideal balance of rigidity and surface characteristics, while offering a high degree of chemical resistance, crack resistance and temperature performance not available with SAN or PMMA. Several biocompatible CET® SMMA grades are available for healthcare applications that meet the necessary biocompatibility requirements.

Moises Romero Manig, Market Development & Business Intelligence Manager at Resirene, said:
“We have already seen some successes in the medical segment for our CET® SMMA material. With Foster’s expertise in this segment, we are confident that this collaboration will help to accelerate our growth here.”

Larry Johnson, Executive Vice President for Foster Corporation; said:
“Our current customers and prospects serving the medical segment are always looking for new transparent material options that can help them to meet the performance requirements and regulatory approvals while contributing to cost-savings initiatives. We’re proud to bring Resirene’s CET® SMMA into our portfolio of solutions.”

PS: If you liked this News, you might enjoy our Plastics & Elastomers Industry Newsletter. All the Industry News delivered twice a week right to your inbox. Sign up here!

Source: Resirene
The Chemicals Sales & Marketing Toolbox
Channel Alerts

Receive weekly digests on hot topics

Back to Top